# IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

> **NCT06139328** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 160 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** BI 765845
- **DRUG:** Placebo matching BI 765845

## Key facts

- **NCT ID:** NCT06139328
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-05
- **Primary completion:** 2025-09-02
- **Final completion:** 2025-12-02
- **Target enrollment:** 160 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139328, "IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06139328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*